Hengrui Medicine (01276) plans to repurchase 1 billion to 2 billion yuan of A-share stocks.

Wisdom Financial News APP reports that Hengrui Medicine (01276) announced that based on the confidence in the company's future development prospects and fundamental judgment, in order to protect the interests of the company and the general investors, improve the long-term incentive mechanism for employees, and fully mobilize the enthusiasm of employees, the company plans to repurchase A-shares with its own funds. The total amount of funds used for repurchase shall not be less than RMB 1 billion and not more than RMB 2 billion, and the repurchase price shall not exceed RMB 90.85 per share (inclusive). The repurchased shares will be used for the A-share employee stock ownership plan.